Northrop Grumman Corporation Q2 FY26 Earnings Analysis
Published 29 May 2026 | Aerospace and Defense | Market Cap: ₹79.4K Cr
Price
₹559.29
Market Cap
₹79.4K Cr
P/E Ratio
17.5
Revenue Rank
Margin Rank
Earnings Summary
- Mid-single-digit sales growth expected for the full year 2026, supported by a near-record $96 billion backlog providing over 2 years of sales coverage. - Mid-single-digit sales growth expected for 2026, with full-year sales guidance reaffirmed between $43.5 billion and $44 billion.
📊 Revenue & Sales Performance
Rank 4- Mid-single-digit sales growth expected for the full year 2026, supported by a near-record $96 billion backlog providing over 2 years of sales coverage. - Multiple new bidding opportunities could drive higher sales growth beyond mid-single digits. - Accelerated ramp-up expected in missile components production, especially solid rocket motors, contingent on contract awards. - International sales pipeline growing, with long-term potential to become a key contributor, though international contracts typically have longer cycles. - Sentinel program projected to grow at low double digits in 2026, moving toward 10% of company revenue over time. - B-21 program nearing 10% of revenue, expected to exceed that in coming years with accelerated production. - Weapons business (including missile defense) nearing 10% of sales, anticipated to be one of the fastest-growing segments. - Overall, growth driven by strong demand across missile defense, munitions, B-21, and Sentinel programs, plus emerging international opportunities.
📈 Profitability & Margins
Rank 3- Mid-single-digit sales growth expected for 2026, with full-year sales guidance reaffirmed between $43.5 billion and $44 billion. (Page 4) - Sentinel program expected to grow low double digits this year and aim toward 10% of total revenue over time. (Page 8) - B-21 program nearing 10% of revenue and expected to exceed 10% over the next several years with accelerated production. (Page 8) - Weapons business close to 10% of sales, anticipated to be one of the fastest-growing segments, driven by munitions and new programs. (Page 8) - Operating margin projected in the low to mid-11% range for 2026, with expected margin improvements through the year due to production timing and mix. (Page 4) - EPS for Q1 2026 was $6.14, up substantially from the prior year, driven by higher sales and operating income. (Page 4) - Free cash flow guidance maintained at $3.1 billion to $3.5 billion despite higher capital investments. (Page 4) - Future margin expansion is possible as programs mature and manufacturing capabilities improve, subject to competitive environment. (Page 9)
🏗️ Capital Expenditure Plans
Yes- $200 million CapEx planned for 2026 to support increased production capacity on the B-21 program. - Majority of capital expenditures for B-21 expected in 2027, 2028, and 2029, largely to be completed this decade. - Investment in modernizing solid rocket motor (SRM) and munition technologies totaling over $2 billion made in recent years, with further production expansion completing by 2027. - New production facilities for weapons business are modular and adaptable to flex with demand. - Company investing approximately $2.5 billion for B-21 production ramp-up, alongside customer funding from reconciliation package. - Opened a new facility specifically for accelerating radar production to meet program requirements, including tooling and workforce training completed. - CapEx investments aimed at scaling capacity to meet growing demand, supporting sales growth and long-term profitability.
💰 Fundraising & Capital Structure
No information- In Q1, the company repaid $527 million of fixed rate debt, ending the quarter with over $2 billion in cash on hand, indicating no immediate need for new debt financing. - Capital expenditures are planned to increase to $1.85 billion in 2026, primarily to support increased production capacity, especially for the B-21 program. - The company did not announce any new fundraising activities through debt or equity. - Free cash flow guidance for 2026 remains strong at $3.1 billion to $3.5 billion, with efforts underway to offset impacts from increased capital investments. - No mention was made of plans for issuing new equity or additional debt in the near future. - The company appears focused on funding growth internally through cash flow and managing existing capital allocations.
📋 Order Book & Pipeline
Yes- Northrop Grumman's backlog stands at approximately $96 billion, providing over 2 years of sales coverage. - The company continues to see strong bookings, reinforcing growth prospects into next year. - Reconciliation dollars from recent defense budgets are starting to flow into contracts in 2026. - There are numerous new bidding opportunities underway, including international and U.S. defense programs. - The company is working to convert a robust international pipeline into firm orders, though international contracts tend to have longer cycles. - The 2027 defense budget request of $1.5 trillion, including increased funding for key programs like B-21 and Sentinel, indicates sustained demand. - Long-term demand signals and structured production frameworks with the Department of Defense support continued backlog growth. - Awards such as Lot 4 LRIP for B-21 and MDA awards (e.g., GPI) add to confirmed orders, with some contract decisions expected in Q3 2026.
Key Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were Northrop Grumman Corporation Q2 FY26 results?
- Mid-single-digit sales growth expected for the full year 2026, supported by a near-record $96 billion backlog providing over 2 years of sales coverage. - Mid-single-digit sales growth expected for 2026, with full-year sales guidance reaffirmed between $43.5 billion and $44 billion.
What is Northrop Grumman Corporation share price analysis?
Northrop Grumman Corporation currently shows a neutral. The stock trades at a P/E of 17.5 with a market cap of $79,438. Investors should review the full earnings analysis for detailed insights.
Is Northrop Grumman Corporation planning capital expenditure?
- $200 million CapEx planned for 2026 to support increased production capacity on the B-21 program.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
